Sysmex ADR Research and Development Expenses 2016-2024 | SSMXY
Sysmex ADR annual/quarterly research and development expenses history and growth rate from 2016 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Sysmex ADR research and development expenses for the quarter ending June 30, 2024 were $0.047B, a 5.83% decline year-over-year.
- Sysmex ADR research and development expenses for the twelve months ending June 30, 2024 were $0.152B, a 15.28% decline year-over-year.
- Sysmex ADR annual research and development expenses for 2024 were $0.208B, a 9.52% decline from 2023.
- Sysmex ADR annual research and development expenses for 2023 were $0.23B, a 3.58% decline from 2022.
- Sysmex ADR annual research and development expenses for 2022 were $0.238B, a 17.51% increase from 2021.
| Sysmex ADR Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $208 |
| 2023 | $230 |
| 2022 | $238 |
| 2021 | $203 |
| 2020 | $200 |
| 2019 | $176 |
| 2018 | $158 |
| 2017 | $139 |
| 2016 | $0 |
| Sysmex ADR Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | $47 |
| 2023-12-31 | |
| 2023-06-30 | $52 |
| 2022-06-30 | $53 |
| 2021-06-30 | $50 |
| 2020-06-30 | $46 |
| 2019-06-30 | $45 |
| 2018-06-30 | $39 |
| 2017-06-30 | $33 |
| 2016-06-30 | $36 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.776B | $3.197B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.408B | 24.08 |
| Intuitive Surgical (ISRG) | United States | $196.120B | 102.54 |
| Alcon (ALC) | Switzerland | $42.207B | 28.24 |
| Edwards Lifesciences (EW) | United States | $41.510B | 26.36 |
| IQVIA Holdings (IQV) | United States | $35.864B | 19.76 |
| IDEXX Laboratories (IDXX) | United States | $34.273B | 40.36 |
| DexCom (DXCM) | United States | $29.084B | 43.80 |
| Waters (WAT) | United States | $21.880B | 32.35 |
| STERIS (STE) | Ireland | $21.298B | 24.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.458B | 0.00 |
| Hologic (HOLX) | United States | $18.284B | 19.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 13.24 |
| Globus Medical (GMED) | United States | $11.562B | 29.28 |
| Penumbra (PEN) | United States | $9.230B | 90.41 |
| Masimo (MASI) | United States | $9.055B | 43.81 |
| Teleflex (TFX) | United States | $8.854B | 14.12 |
| Glaukos (GKOS) | United States | $7.765B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.929B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| Veracyte (VCYT) | United States | $3.018B | 90.56 |
| Inari Medical (NARI) | United States | $2.913B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.807B | 16.21 |
| TransMedics (TMDX) | United States | $2.663B | 84.40 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 18.44 |
| Elekta AB (EKTAY) | Sweden | $2.125B | 17.31 |
| Tandem Diabetes Care (TNDM) | United States | $2.019B | 0.00 |
| RxSight (RXST) | United States | $1.816B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.775B | 9.27 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Artivion (AORT) | United States | $1.175B | 77.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.828B | 14.08 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.714B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.548B | 12.91 |
| SiBone (SIBN) | United States | $0.515B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 32.40 |
| Tactile Systems Technology (TCMD) | United States | $0.383B | 20.70 |
| CVRx (CVRX) | United States | $0.358B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.315B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| NeuroPace (NPCE) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.150B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.67 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |